Shukra Pharmaceuticals Ltd
Shukra Pharmaceuticals Ltd Live Price Chart
Performance
| Previous Close | ₹ 44.28 |
| High | ₹ 46.2 |
| Volume | 226746 |
| 52W Range | ₹ 25.7 - ₹ 65.26 |
| Open | ₹ 45.66 |
| Low | ₹ 44.35 |
| Market Cap | ₹ 1388.95 Cr |
Shukra Pharmaceuticals Ltd Technicals
| 20 Day | ₹ 41.065 |
| 50 Day | ₹ 37.211 |
| 100 Day | ₹ 35.748 |
| 200 Day | ₹ 34.690 |
| 20 Day | ₹ 40.862 |
| 50 Day | ₹ 35.365 |
| 100 Day | ₹ 33.318 |
| 200 Day | ₹ 38.585 |
Shukra Pharmaceuticals Ltd Fundamentals
| ROCE | 31.449 |
| P/E Ratio | 54.180 |
| P/B Ratio | 20.350 |
| Industry P/E | 20.350 |
| Debt to Equity | 51.431 |
| ROE | 24.543 |
| EPS | 0.820 |
| Dividend Yield | 0.020 |
| Book Value | 2.184 |
| Face Value | 1.000 |
Shukra Pharmaceuticals Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 | Y202203 | Y202103 |
|---|---|---|---|---|---|
| Total Revenue | 36.794 | 77.3881 | 60.0304 | 20.567 | 11.5523 |
| Total Expenses | 23.4575 | 57.5048 | 55.5887 | 19.549 | 11.2592 |
| Profit After Tax | 9.5751 | 18.5372 | 4.4065 | 0.7507 | 0.1881 |
Shukra Pharmaceuticals Ltd Shareholding Pattern
| Promoter Holdings | 51.152 % |
| FIIs | 0.003 % |
| DIIs | 0.114 % |
| MutualFund | 0.000 % |
| Retail | 9.339 % |
| Others - | 39.392 % |
About Shukra Pharmaceuticals Ltd
Shukra Pharmaceuticals Limited, formerly known Relish Pharmaceuticals Limited was established in March, 1993 and later on the Company name was changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on September 22, 2016. The Company is presently engaged in the business of manufacturing and trading of pharmaceuticals formulations and laboratory testing. The company provides varieties of products to the clientele. Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others. The company has four manufacturing divisions namely tablets (General and Beta Lactum) Capsules (General and Beta Lactum), Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat. The company customers include leading Manufacturers like Cadila Healthcare Limited (Zydus), Intas Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Makers Laboratories Limited, Agenta Pharma Limited etc. The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 44.71 +1.54 (+3.57%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 510.00 -5.35 (-1.04%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 7,100.00 -6.25 (-0.09%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 616.40 +29.35 (+5%) |
| Abbott India Ltd Pharmaceuticals | ₹ 25,900.00 -395.7 (-1.5%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,416.00 -2 (-0.14%) |
FAQs on Shukra Pharmaceuticals Ltd
1. Can I buy Shukra Pharmaceuticals Ltd from PL Capital? ›
2. Does Shukra Pharmaceuticals Ltd pay dividends? ›
3. What is the current share price of Shukra Pharmaceuticals Ltd ? ›
4. What is the 52-week high and low of Shukra Pharmaceuticals Ltd ? ›
Start SIP in Shukra Pharmaceuticals Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
